Cargando…

Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis Based on a Systematic Literature Review

BACKGROUND: New agents with neuroprotective or neuroregenerative potential might be explored in primary-progressive Multiple Sclerosis (PPMS) - the MS disease course with leading neurodegenerative pathology. Identification of patients with a high short-term risk for progression may minimize study du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stellmann, Jan-Patrick, Neuhaus, Anneke, Lederer, Christian, Daumer, Martin, Heesen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961431/ https://www.ncbi.nlm.nih.gov/pubmed/24651401 http://dx.doi.org/10.1371/journal.pone.0092761

Ejemplares similares

Ecological Validity of Walking Capacity Tests in Multiple Sclerosis
por: Stellmann, J. P., et al.
Publicado: (2015)

Prognostic Risk Estimates of Patients with Multiple Sclerosis and Their Physicians: Comparison to an Online Analytical Risk Counseling Tool
por: Heesen, Christoph, et al.
Publicado: (2013)

Placebo Cohorts in Phase-3 MS Treatment Trials – Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data
por: Stellmann, Jan-Patrick, et al.
Publicado: (2012)

Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
por: Stürner, Klarissa Hanja, et al.
Publicado: (2019)

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting
por: von Gumberz, Johanna, et al.
Publicado: (2016)

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018)

Impairment and restrictions in possibly benign multiple sclerosis
por: Schaefer, Laura Melanie, et al.
Publicado: (2019)

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
por: Galea, I, et al.
Publicado: (2013)

Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)—Results of a Pilot Randomized Controlled Trial
por: Heinrich, Inga, et al.
Publicado: (2021)

Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals
por: Zhai, Yuyang, et al.
Publicado: (2020)

Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis
por: Daumer, M, et al.
Publicado: (2007)

Reduced rich-club connectivity is related to disability in primary progressive MS
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis
por: Thaler, Christian, et al.
Publicado: (2017)

T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis
por: Thaler, Christian, et al.
Publicado: (2021)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging
por: Faizy, Tobias Djamsched, et al.
Publicado: (2016)

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients
por: Thaler, Christian, et al.
Publicado: (2015)

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme
por: Brand, Judith, et al.
Publicado: (2014)

Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis
por: Stellmann, Jan-Patrick, et al.
Publicado: (2021)

Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D
por: Chorschew, Anna, et al.
Publicado: (2023)

Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

Delayed access to conscious processing in multiple sclerosis: Reduced cortical activation and impaired structural connectivity
por: Has Silemek, Arzu C., et al.
Publicado: (2021)

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2020)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

Correction: Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients
por: Bester, Maxim, et al.
Publicado: (2015)

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
por: Scalfari, Antonio, et al.
Publicado: (2010)

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
por: Jarius, S., et al.
Publicado: (2018)

Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging
por: Thaler, Christian, et al.
Publicado: (2021)

Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
por: Stellmann, Jan-Patrick, et al.
Publicado: (2015)

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients
por: Stellmann, JP, et al.
Publicado: (2015)

Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months
por: Nasseri, Navina N., et al.
Publicado: (2020)

Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period
por: Faizy, Tobias Djamsched, et al.
Publicado: (2017)

The MRZ reaction in primary progressive multiple sclerosis
por: Hottenrott, Tilman, et al.
Publicado: (2017)

Reducing the probability of false positive research findings by pre-publication validation – Experience with a large multiple sclerosis database
por: Daumer, Martin, et al.
Publicado: (2008)

Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple Sclerosis
por: Golde, Sabrina, et al.
Publicado: (2020)

Driving ability and predictors for driving performance in Multiple Sclerosis: A systematic review
por: Seddiq Zai, Susan, et al.
Publicado: (2022)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry—A Cross-Sectional Study
por: Schimpl, Michaela, et al.
Publicado: (2011)

Validation of Computer-Adaptive Contrast Sensitivity as a Tool to Assess Visual Impairment in Multiple Sclerosis Patients
por: Rosenkranz, Sina C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2omg4bnjlhmh703khnhqfb6oev